Search Results
Edit Save
5,935 results
Healio News 03/24/2019 17:15
NEW ORLEANS — Oral semaglutide, as an add-on to metformin with or without a sulfonylurea, resulted in greater HbA1c reductions after 26 weeks compared with sitagliptin, according to new data from the PIONEER 3 trial. The mean change in HbA1c from baseline to 26 weeks — the primary endpoint — was –0.6% with semaglutide 3 mg per day, –1% with semaglutide 7 mg per day and –1.3% with semaglutide 15 mg per day compared with –0.8% with sitagliptin (Januvia, Merck) 100 mg per day. The 7-mg and 14-mg daily doses of semaglutide were superior to sitagliptin for.
Healio News 03/24/2019 17:10
NEW ORLEANS — The presence of endocrine-disrupting chemicals in household dust promoted the development of fat cells in a cell model, researchers reported at the Endocrine Society Annual Meeting. “This is some of the first research investigating links between exposure to chemical mixtures present in the indoor environment and metabolic health of children living in those homes,” Christopher D. Kassotis, PhD, postdoctoral research associate at Duke University’s Nicholas School of the Environment, said in a press release. This research group previously demonstrated that.
Healio News 03/24/2019 15:30
FORT LAUDERDALE, Fla. — The use of plasma rich in growth factors for recurrent macular hole closures in a pilot study showed success in two patients over a 12-month follow up period, according to a speaker here. “The use of plasma rich in growth factors can lead to anatomical and functional satisfactory results for recurrent macular holes. It could become an optional surgical technique in cases of recurrent macular holes,” Juan Arias, MD, said at the Retina World Congress. The pilot study included two patients with recurrent macular holes. Primarily investigated for ocular.
Healio News 03/24/2019 11:00
WHO fully released new treatment guidelines for multidrug-resistant tuberculosis, or MDR-TB, and announced a package of actions it said is designed to help countries close gaps in care. The actions were taken ahead of World TB Day, observed each year on March 24. “To win the fight against TB, multisectoral accountability, engagement and action is vital,” Tereza Kasaeva, MD, PhD, director of WHO’s Global TB Programme, told Infectious Disease News. WHO previewed the new MDR-TB guidelines last year. They recommend shifting to a fully oral regimen. According a news release, a “larger.
Healio News 03/24/2019 10:30
FORT LAUDERDALE, Fla. — The proportion of patients with a 2 or more-step improvement in non-proliferative diabetic retinopathy scores was significantly greater when treated with aflibercept compared to a sham, according to a speaker here. “PANORAMA is the first large, prospective trial of high risk, non-proliferative diabetic retinopathy patients since the Early Treatment Diabetic Retinopathy Study,” W. Lloyd Clark, MD, said at the Retina World Congress. Clark presented the 52-week results of the PANORAMA study, a phase 3, double-masked study that evaluated the efficacy and.
Healio News 03/24/2019 07:00
James Findling, MD, is a veteran of the endocrinology field, a clinical practitioner and a Cushing’s syndrome expert. For his efforts in these areas, particularly clinical practice, the Endocrine Society is honoring him with its Outstanding Clinical Practitioner Award at ENDO 2019 in New Orleans. Findling, who currently serves as director of community endocrinology services and clinical professor of medicine at the Medical College of Wisconsin in Milwaukee, has made his clinical practice a national one as, according to the Endocrine Society, he receives referrals from across the U.S. In.
Healio News 03/23/2019 22:26
NEW YORK – Clark Chang, OD, MSA, MSc, FAAO, gave a talk on cataract surgery problem-solving here at Vision Expo East and said communication is a big component. He said to be sure to ask patients if they take Flomax (tamsulosin, Sanofi-Aventis), particularly a generic form. He said to communicate that with the surgeon, so they are completely aware and can prepared for potential floppy iris syndrome.
Healio News 03/23/2019 21:54
NEW YORK – Our behaviors and actions are contagious to those around us, and the most contagious person in the eye care practice is the optometrist leader, according to Michael A. Kling, OD, here at Vision Expo East. Kling said we are biologically hard-wired to imitate one another, and “it’s important that you realize the impact you have on your organization,” he said.
Healio News 03/23/2019 18:43
NEW YORK – North, a young technology company, introduced its new smart glasses, Focals, here at Vision Expo East. North chief marketing officer Adam Ketcheson told Primary Care Optometry News that Focals are “everyday smart glasses” intended to be a useful tool to help the wearer stay connected discreetly. Alexander Ingram, head of communications for North, said Focals look like regular glasses but they are connected to your calendar, texts, Uber, navigation and other services. Focals are not designed for gaming or augmented or virtual reality, Ketcheson said. The wearer sees a.
Healio News 03/23/2019 17:44
NEW ORLEANS — This year’s Endocrine Society Annual Meeting reflects a renewed effort to expand the organization’s outreach and membership through new initiatives and strategic partnerships, according to society president Susan J. Mandel, MD, MPH. “I am truly thrilled to welcome you to a meeting of exploration and collegiality, filled with outstanding science, state-of-the-art clinical care, and lots of opportunities to network and have fun,” Mandel, director of clinical endocrinology and diabetes at the University of Pennsylvania Health System, said during the meeting’s.

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications